ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 182 filers reported holding ARCUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,281,652 | -12.6% | 238,532 | -1.1% | 0.06% | -3.0% |
| Q2 2023 | $4,898,552 | +17.7% | 241,189 | +5.7% | 0.07% | -2.9% |
| Q1 2023 | $4,160,748 | -15.8% | 228,111 | -4.5% | 0.07% | -25.0% |
| Q4 2022 | $4,939,194 | -21.7% | 238,839 | -1.0% | 0.09% | -16.4% |
| Q3 2022 | $6,311,000 | +12.1% | 241,227 | +8.6% | 0.11% | +10.0% |
| Q2 2022 | $5,628,000 | -38.8% | 222,082 | -23.8% | 0.10% | +17.6% |
| Q1 2022 | $9,193,000 | -22.4% | 291,280 | -0.5% | 0.08% | +26.9% |
| Q4 2021 | $11,844,000 | +16.7% | 292,668 | +0.6% | 0.07% | +26.4% |
| Q3 2021 | $10,147,000 | +24.4% | 291,003 | -2.0% | 0.05% | +32.5% |
| Q2 2021 | $8,158,000 | -4.5% | 297,088 | -2.3% | 0.04% | -13.0% |
| Q1 2021 | $8,542,000 | +4.2% | 304,212 | -3.7% | 0.05% | +12.2% |
| Q4 2020 | $8,198,000 | -45.1% | 315,811 | -63.7% | 0.04% | -55.4% |
| Q3 2020 | $14,923,000 | -25.1% | 870,634 | +8.1% | 0.09% | -41.0% |
| Q2 2020 | $19,918,000 | +7039.1% | 805,074 | +3899.4% | 0.16% | +5100.0% |
| Q1 2020 | $279,000 | +29.2% | 20,130 | -5.7% | 0.00% | +50.0% |
| Q4 2019 | $216,000 | +13.7% | 21,356 | +2.1% | 0.00% | 0.0% |
| Q3 2019 | $190,000 | +16.6% | 20,915 | +2.3% | 0.00% | 0.0% |
| Q2 2019 | $163,000 | – | 20,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |